Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) 3-Year Dividend Growth Rate : 0.00% (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Staidson (Beijing) Biopharmaceuticals Co 3-Year Dividend Growth Rate?

Staidson (Beijing) Biopharmaceuticals Co's Dividends per Share for the three months ended in Mar. 2025 was ¥0.00.

The historical rank and industry rank for Staidson (Beijing) Biopharmaceuticals Co's 3-Year Dividend Growth Rate or its related term are showing as below:

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Staidson (Beijing) Biopharmaceuticals Co was 52.30% per year. The lowest was 17.80% per year. And the median was 29.20% per year.

SZSE:300204's 3-Year Dividend Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 10.2
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Staidson (Beijing) Biopharmaceuticals Co's Dividend Payout Ratio for the three months ended in Mar. 2025 was 0.00. As of today, Staidson (Beijing) Biopharmaceuticals Co's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Staidson (Beijing) Biopharmaceuticals Co's 3-Year Dividend Growth Rate

For the Biotechnology subindustry, Staidson (Beijing) Biopharmaceuticals Co's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Staidson (Beijing) Biopharmaceuticals Co's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Staidson (Beijing) Biopharmaceuticals Co's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Staidson (Beijing) Biopharmaceuticals Co's 3-Year Dividend Growth Rate falls into.

Save Embed

;

Save Embed

;

Staidson (Beijing) Biopharmaceuticals Co 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Staidson (Beijing) Biopharmaceuticals Co's Dividend Payout Ratio for the quarter that ended in Mar. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2025 )	/	EPS without NRI (Q: Mar. 2025 )
	=	0	/	0
	=	N/A

During the past 13 years, the highest Dividend Payout Ratio of Staidson (Beijing) Biopharmaceuticals Co was 22.27. The lowest was 0.33. And the median was 0.37.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 13 years, the highest Dividend Yield of Staidson (Beijing) Biopharmaceuticals Co was 6.68%. The lowest was 0.13%. And the median was 1.24%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Staidson (Beijing) Biopharmaceuticals Co 3-Year Dividend Growth Rate Related Terms>

Staidson (Beijing) Biopharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Staidson (Beijing) Biopharmaceuticals Co Ltd (SZSE:300204) » Definitions » 3-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rongjing Dong Street, No 5 Beijing Economic and Technological Development Zone, Beijing, CHN, 100176

Website

http://www.staidson.com

Staidson (Beijing) Biopharmaceuticals Co Ltd is a pharmaceutical company mainly engaged in the research, development, production, and sale of biological products in China. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin.

Executives

Zhang Hong Shan	Supervisors
Zheng Hong	Supervisors
Cheng Jiang Hong	Executives
Feng Yu Jing	Executives
Ma Li Na	Secretary, Director
Zhou Zhi Wen	Director
Wang Huan	Securities Affairs Representative
Zhang Rong Qin	Executives
Xu Jiang Ping	Executives
Cao Hai Yan	Supervisors
Sun Yan Fang	Executives
Jiang Li Xin	Director
Gu Jian Ping	Director
Xu Xiang Qing	Supervisors
Gu Zhen Qi	Director

Staidson (Beijing) Biopharmaceuticals Co Headlines

No Headlines